Cyclosporin A augments human platelet sensitivity to aggregating agents by increasing fibrinogen receptor availability
Open Access
- 31 August 1991
- journal article
- Published by Elsevier in Journal of Surgical Research
- Vol. 51 (2), 93-98
- https://doi.org/10.1016/0022-4804(91)90076-x
Abstract
No abstract availableKeywords
This publication has 19 references indexed in Scilit:
- Microangiopathy in patients on cyclosporine prophylaxis who developed acute graft-versus-host disease after HLA-identical bone marrow transplantationBlood, 1989
- Renal Vascular and Thrombotic Effects of CyclosporineAmerican Journal of Kidney Diseases, 1989
- Increased urinary excretion of thromboxane B2 and 2,3-dinor-TxB2 in cyclosporin A nephrotoxicityKidney International, 1988
- Cyclosporine A enhances platelet aggregationKidney International, 1987
- Fibrinogen interaction with platelets of diabetic subjectsThrombosis Research, 1987
- Detection of thromboxane B2 in peripheral blood of patients with Prinzmetal's anginaProstaglandins and Medicine, 1979
- Preservation of human platelets with prostaglandin E1 during in vitro simulation of cardiopulmonary bypass.Circulation Research, 1979
- Clofibrate Reversal of Platelet Hypersensitivity in HyperbetalipoproteinemiaCirculation, 1974
- Preparation of Suspensions of Washed Platelets from HumansBritish Journal of Haematology, 1972
- THE ATTRACTIONS OF PROTEINS FOR SMALL MOLECULES AND IONSAnnals of the New York Academy of Sciences, 1949